# Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-outcomes-and-secondary-epidermal-growth-factor-receptor-egfr-t790m/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yen‐Ting Lin,Jin‐Shing Chen,Wei‐Yu Liao,Chao‐Chi Ho,Chia‐Lin Hsu,Ching‐Yao Yang,Kuan‐Yu Chen,Jih‐Hsiang Lee,Zhong‐Zhe Lin,Jin‐Yuan Shih,James Chih‐Hsin Yang,Chong‐Jen Yu |
| Citations | 65 |
| DOI | 10.1002/ijc.32025 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.32025 |
| OpenAlex ID | https://openalex.org/W2902148775 |
| PMID | 30485437 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Yen‐Ting Lin](https://scholariq.org/researchers/yen-ting-lin/)

## Paper journal

- [International Journal of Cancer](https://scholariq.org/journals/international-journal-of-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.